| abstract |
The invention relates to the use of a medicament for reducing elevated plasma levels of LDL and / or triglycerides in an HIV-infected patient. Atazanavir (BMS-232632) may be used to treat HIV infection in patients with elevated plasma LDL-cholesterol and / or triglyceride levels, may replace a harmful HIV protease inhibitor used in therapy, or may be used with HIV protease inhibitor that is metabolized by P450 monooxygenase. a |